In terms of subgroup analysis, KIF-12 showed significant expression differences in the T1 and T2 tumour stage subsets, M0 and N1 stage subsets, classical PTC, female population, BRAF mutation group, patients with unifocal neoplasm and patients aged ≤ 45 [Figure 2]. This evidence concerns the gene BRAF and neoplasm.